CEO

​​

Dr. Dvashi has 10 years of experience in the biomedical field, including 8 years of management in the biotech industry, business, operational, financial, clinical and regulatory activities. 

Dr. Dvashi served as Chief Technology Officer (CTO) at OphtimedRx, a small start-up company that develops innovative drugs for retinal pathologies. In addition, Dr. Dvashi served as technology expert (Biotechnology & Therapeutics) at SNE-IP. Dr. Dvashi received his Ph.D degree from the Cell Research and Immunology Department, Tel Aviv University. Dr. Dvashi is the author of 8 scientific publications and 1 book chapter and inventor of 5 patents applications.